vincristine

Feinstein researchers eye brain-tumor breakthrough

A common medication used to treat parasitic infections could leapfrog to the top of medical science’s brain-cancer arsenal. Pure scientific research funded by federal grants has led to this potential oncological breakthrough by the Feinstein Institute for Medical Research, the research-and-development division of the Northwell Health system. Marc Symons, a professor in the Feinstein Institute’s Karches Center for Oncology Research, is exploring the use of mebendazole – a medication commonly used to treat pinworms –…